Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Infinity Pharmaceuticals (INFI)
OTHER OTC:INFI
Holding INFI?
Track your performance easily
INFI Stock Chart & Stats
Day’s Range$0.01 - $0.02
52-Week Range― - ―
Previous Close$0.02
Volume1.14M
Average Volume (3M)N/A
Market Cap
$1.45M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 01, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Infinity Pharma News
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
11.88% Other Institutional Investors
88.12% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INFI FAQ
What was Infinity Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Infinity Pharmaceuticals’s market cap?
Currently, no data Available
When is Infinity Pharmaceuticals’s upcoming earnings report date?
Infinity Pharmaceuticals’s upcoming earnings report date is Nov 01, 2023 which is 419 days ago.
How were Infinity Pharmaceuticals’s earnings last quarter?
Infinity Pharmaceuticals released its earnings results on Aug 08, 2023. The company reported -$0.111 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.009.
Is Infinity Pharmaceuticals overvalued?
According to Wall Street analysts Infinity Pharmaceuticals’s price is currently Overvalued.
Does Infinity Pharmaceuticals pay dividends?
Infinity Pharmaceuticals does not currently pay dividends.
What is Infinity Pharmaceuticals’s EPS estimate?
Infinity Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Infinity Pharmaceuticals have?
Currently, no data Available
What happened to Infinity Pharmaceuticals’s price movement after its last earnings report?
Infinity Pharmaceuticals reported an EPS of -$0.111 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went up 44.444%.
Which hedge fund is a major shareholder of Infinity Pharmaceuticals?
Among the largest hedge funds holding Infinity Pharmaceuticals’s share is Carlson Capital LP. It holds Infinity Pharmaceuticals’s shares valued at 273K.
---
Company Description
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.
---
INFI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---